PhenGen Biotech Overview
- Founded
- 2012
- Status
- Private
- Latest Deal Type
- Accelerator/Inc
- Investors
- 1
PhenGen Biotech General Information
Description
Provider of gene delivery research services intended for serious unmet need. The company's platform specialises in the latest gene delivery research into therapeutic applications for diseases and develops novel therapeutics and research tools based on recombinant adeno-associated viral vectors, enabling users in research during serious unmet needs.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
- 3711 Market Street 8th Floor
- Philadelphia, PA 19104
- United States
PhenGen Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Jan-2016 | Completed | Startup |
PhenGen Biotech Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Bruno Schremmer MD | Founder & Chief Executive Officer |
PhenGen Biotech Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Science Center | Accelerator/Incubator | 000 0000 | 000000 0 |